We've been working together to make our support services more accessible to the Deaf community.

Learn about the Carol Jennings Fellowship and the people working to stop dementia devastating lives.

The blood-brain barrier acts as a gatekeeper restricting what can and cannot reach the brain. Researchers are now designing the next generation of antibody treatments to cross the blood-brain barrier more effectively.

Professor Fiona Carragher, Chief Policy and Research Officer at Alzheimer’s Society, comments on the Chancellor's Autumn Budget:

A new study, funded by Alzheimer’s Society, has identified three existing medications that could be repurposed to treat or prevent Alzheimer’s disease. 

Researchers are studying whether existing, safe medicines could be adapted to treat dementia. This is known as drug repurposing, and it offers fresh hope for finding effective dementia treatments sooner.